Skip to main content
Top
Published in: Reactions Weekly 1/2019

01-11-2019 | Stroke | Clinical study

Impact of generic valsartan recall due to contamination

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

The recall of six generic versions of valsartan in Canada due to contamination with the carcinogen nitrosodimethylamine (NDMA) was associated with an increase in emergency department (ED) visits due to hypertension and a trend for increased ED visits and hospitalisation due to stroke/transient ischaemic attack (TIA), according to findings of a study published in Circulation. …
Metadata
Title
Impact of generic valsartan recall due to contamination
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-71501-z

Other articles of this Issue 1/2019

Reactions Weekly 1/2019 Go to the issue

Case report

Sodium valproate

Case report

Clofazimine

Case report

Methotrexate

Case report

Sorafenib